MaxCyte, Inc. (MXCT)
NASDAQ·Healthcare·Biotechnology
$1.20
-3.23%
Mkt Cap $136.58M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+400.0%
Consensus $6.00 vs current $1.20
NASDAQ·Healthcare·Biotechnology
$1.20
-3.23%
Mkt Cap $136.58M
No recent rating data.
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
+400.0%
Consensus $6.00 vs current $1.20